Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Noema Pharma Announces NOE-105 (gemlapodect) Phase 2a Study in Tourette Syndrome met Primary and all Key Secondary Endpoints
-
ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025
-
Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial
-
LVT Expands Satellite Internet Connectivity to Augment Cellular Coverage for Mobile Security Solutions
-
Acrivon Therapeutics to Present Data Demonstrating Deployment of its AP3 Platform for Streamlined Drug Discovery and Clinical Development at Two Scientific Conferences - Human Proteome Organization Wo
-
Inovalon Launches AI-Powered Converged Record Review To Improve Risk Score Accuracy for Health Plans
-
Loadsmart Reaches Operating Profitability and Forecasts All-Time Record Gross Profit for the Year
-
Worksport Announces Accelerated Path to Profitability with $2M+ in Projected Savings, Strengthens Financial Stability Ahead Of Upcoming Product Launches
-
TransUnion Report Finds 33% Increase in Number of Property Managers Reporting Rent Payments Since Last Year
-
Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024
-
Bright Peak Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of BPT567, a First-in-Class Bifunctional PD1-IL18 Immunoconjugate
-
Phunware to Attend and Exhibit at The Hospitality Show in San Antonio
-
BairesDev Report Shows Core Tech Skills Are Powering the AI Revolution
-
Listing prospectus for Tornator Oyj's EUR 300 million green notes available; listing application submitted
-
Reporting of trading in Tryg shares by senior management and their related parties
-
ProductLife Group (PLG) Acquires Halloran to Further Expand Its Global Reach and Capabilities to Support the Development of New Therapies
-
US utilities to face significant challenge as power demand surges for the first time in decades
-
EllaLink & SPLANG start construction of subsea cable to French Guiana
-
Tevogen Investors Congratulate on Prestigious Recognition of Pioneering Biopharma Business Model, Breakthrough Innovations, Building Assets Estimated to Exceed $10 Billion
-
ZyVersa Therapeutics CEO, Stephen C. Glover, Issues Letter to Shareholders Highlighting Obesity Development Plans for Inflammasome ASC Inhibitor IC 100 Over the Next Nine Months
-
CoreCard Corporation Schedules Third Quarter 2024 Earnings Release and Conference Call
-
Organic Remedies Donates $80,000 to Support Pennsylvania Court Appointed Special Advocates for Children
-
Golconda Gold Ltd. Releases Q3 2024 Production Update
-
Antelope Enterprise to Provide Energy to the $33.6 Billion US Market through its Completed Acquisition
-
Ocugen to Host Conference Call on Friday, November 8 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2024 Financial Results
-
Bocana Resources Corp. Provides a Corporate Update
-
The Western Investment Company to Hold its Annual General and Special Meeting of Shareholders on December 6, 2024
-
Red Pine discovers additional high-grade veins on surface north of the Jubilee Deposit, Wawa Gold Project
-
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
-
Habit Burger & Grill Announces Free Large PEPSI® with Double Char Purchase
-
Antelope Enterprise to Provide Energy to the $33.6 Billion US Market through its Completed Acquisition
-
ZenaTech’s ZenaDrone Team Begins US Flight Testing of ZenaDrone 1000 in the Arizona Desert
-
Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance
-
Habit Burger & Grill Announces Free Large PEPSI® with Double Char Purchase
-
Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
-
SemiCab Wins Contract with Apollo Tyres, $3 Billion Global Tire Manufacturer, for New Indian Commercial Pilot
-
Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek™ 2024
-
Draganfly to Showcase Latest Drone Innovations at Wings of Saskatchewan in Regina, October 30-31
-
New Survey Data from Rainbow High™ Reveals That Toys Inspire Self-Confidence – 61% of Parents Report Kids Are More Confident with Toys Based on Colors of the Rainbow
-
Emerging Markets Report: A Mushroom Monster in the Making
-
Calian continues to respond to growing demand for global defence solutions
-
Tilray Brands Celebrates Six Years of Cannabis Legalization in Canada with Industry-Leading Innovation in Brands and Products
-
Man Group PLC : Form 8.3 - Keywords Studios plc
-
Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy
-
Chicago Atlantic Real Estate Finance Schedules Third Quarter 2024 Earnings Release and Conference Call Date
-
CIB Marine Bancshares, Inc. Announces Final Redemption of Preferred Stock
-
Harfang Announces High-Grade Gold Discoveries at Menarik East, Québec
-
Guardian Capital Announces October 2024 Cash Distributions for Guardian Capital ETFs
-
Brunswick Exploration Outlines Significant New Lithium Potential in Tills at Anatacau West
-
Helium Evolution Announces Key Well Licenses Obtained
